Kevin O'Connell's contract situation is a major talking point in the early stages of the Vikings' offseason. Next season will ...

The major indexes reclaimed their 50-day moving averages while bitcoin also rallied into Donald Trump's presidential inauguration. Many stocks flashed buy signals.

What are the Minnesota Vikings going to do about the Kevin O’Connell contract/trade rumors that continue to circulate around ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating for Viking Holdings, raising the price target to $58 from $50.

In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...

The loss of a still-capable bridge/back-up quarterback could be mitigated by the presence of Daniel Jones. The 27-year-old ...

H.C. Wainwright analyst Joseph Pantginis has reiterated their bullish stance on VKTX stock, giving a Buy rating on January 9.Stay Ahead of the ...

After Novo Nordisk (NVO) reported results from its Phase 3b STEP UP trial, which showed that adults with obesity achieved a 20.7% weight loss ...

New York-based private equity firm Clarion Capital Partners completed its acquisition of Marketplace Events (MPE), a leading ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Several NFL teams need a franchise quarterback and Darnold proved he can be that guy in Minnesota, becoming the first ...

The Minnesota Vikings have entered yet another offseason with significant questions around their quarterback depth chart.